Praxis für Neurologie und Psychiatrie
- Address
- lock Available on a paid plan
Praxis für Neurologie und Psychiatrie - Neurology and Psychiatry Center
This specialized neurology and psychiatry practice focuses on advanced clinical research in neurological disorders, with particular expertise in immune-mediated conditions of the central nervous system. The center participates in cutting-edge trials evaluating novel therapeutic approaches for complex neurological diseases.
- Relapsing Multiple Sclerosis (RMS) treatment research
- Comparative efficacy studies of disease-modifying therapies
- Immunomodulatory treatment strategies in neuroinflammatory conditions
The practice demonstrates significant commitment to multiple sclerosis research, conducting sophisticated clinical trials that compare innovative targeted therapies such as Bruton's tyrosine kinase (BTK) inhibitors with established immunomodulatory agents. Their research focuses on measuring critical clinical outcomes including annualized relapse rates and evaluating both efficacy and safety profiles of emerging neurological treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis für Neurologie und Psychiatrie
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS | F. Hoffmann-La Roche AG | Phase III | Not Recruiting | Dec 2020 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fenebrutinib | 1 | Unknown | 2020-12-09 | 2020-12-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.